Informa Pharma Intelligence announces the launch of its Citeline Connect

Informa Pharma Intelligence launches an all-in-one clinical trial recruitment platform, Citeline Connect to help meet recruitment goals.

FREMONT, CA: Informa Pharma Intelligence has launched Citeline Connect, an all-in-one clinical trial recruitment platform that allows trial enrollment via a pioneering combination of technology and services.

apart from the platform's proprietary technology, the Citeline Connect Patient Recruitment Collective provides study sponsors with access to 75-plus recruitment partners simultaneously, with the potential to reach over 10 million patients. Using a traditional RFP or Citeline Connects industry-first, pay-per-performance model, sponsors can tap into the collective to launch a recruitment campaign and begin pre-screening and enrolling participants.

Citeline Connect  combines:

An online experience platform that powers and sponsors a clinical trial website designed to educate the public about the research process and help them find locally recruiting clinical trials.

A patient enrollment hub that uses pre-screening technology to ensure only qualified participants are referred to the appropriate study site location.

A HIPAA-compliant communications portal that captures patient contact information so clinical trial sponsors can communicate with prospective participants about relevant upcoming trials.

“We are shifting the industry paradigm for clinical trial recruitment,” said Jeff Kozloff, CEO of Citeline Connect. “While the COVID-19 pandemic has increased public awareness of the importance of clinical trials, there remain numerous barriers to participation. Citeline Connect addresses these challenges through an end-to-end platform, from patient engagement to searching for trials to actual enrollment, all supported by the largest collective of pre-vetted recruitment partners and advocacy groups. Our platform enables study sponsors to take clinical trial transparency to the next level.”

Citeline Connect, earlier known as TrialScope Connect, has already been used to recruit for several high-profile COVID-19 vaccine trials, including Modernas COVE study, successfully helping to meet recruitment goals for diverse populations. To date, the platform supports the clinical trial websites of 23 study sponsors and 17 nonprofit organizations, with dozens of clinical trials actively recruiting on the platform.